Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Cash from Operations (2016 - 2025)

STRATA Skin Sciences' Cash from Operations history spans 14 years, with the latest figure at 64000.0 for Q3 2025.

  • For Q3 2025, Cash from Operations rose 78.81% year-over-year to 64000.0; the TTM value through Sep 2025 reached 1852000.0, down 316.36%, while the annual FY2024 figure was 188000.0, 136.22% up from the prior year.
  • Cash from Operations for Q3 2025 was 64000.0 at STRATA Skin Sciences, up from 1941000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 1371000.0 in Q4 2023 and bottomed at 2020000.0 in Q3 2023.
  • The 5-year median for Cash from Operations is 56000.0 (2022), against an average of 121157.89.
  • The largest annual shift saw Cash from Operations soared 1791.07% in 2023 before it crashed 428.43% in 2025.
  • A 5-year view of Cash from Operations shows it stood at 669000.0 in 2021, then crashed by 73.24% to 179000.0 in 2022, then soared by 665.92% to 1371000.0 in 2023, then crashed by 48.72% to 703000.0 in 2024, then plummeted by 109.1% to 64000.0 in 2025.
  • Per Business Quant, the three most recent readings for SSKN's Cash from Operations are 64000.0 (Q3 2025), 1941000.0 (Q2 2025), and 550000.0 (Q1 2025).